About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Pharma Companies Can Influence Medical Journalists By Offering Sops: Report

by VR Sreeraman on November 22, 2008 at 3:02 PM
Font : A-A+

 Pharma Companies Can Influence Medical Journalists By Offering Sops: Report

A team of Dartmouth researchers says that there is a need for greater scrutiny of the relationship between medical journalists and health care industrial sources, as pharmaceutical companies can influence the media by offering some sops.

Steven Woloshin, an associate professor of Medicine and of Community And Family Medicine, says that there are three areas where journalists might become entangled in conflict-of-interest issues: during educational activities that may be drug company sponsored, when accepting sponsored awards, or in the day-to-day practice of reporting the news by relying too heavily on industry supplied sources.

Advertisement

"The media play a role as society's watchdogs. Good medical journalism can expose links between doctors and rewards from pharmaceutical companies. But who's looking to see whether the journalists are being influenced?" writes Woloshin, an author on the paper that has been published in the British Medical Journal (BMJ), titled "Who's Watching the Watchdogs? Medical Journalism and Entanglement".

The report says that relationships between drug companies and journalists may lead to more favourable news stories, in the same manner as industry funding of medical research results in more favourable research outcomes.
Advertisement

As regards education, Woloshin says: "Corporate funding and sponsorships are not new to academia, but we think that there is the possibility that a sponsor could subtly invoke a sense of loyalty from a journalist. There should be no such temptation for journalism students or their teachers."

Woloshin, who jointly wrote the report with Associate Professor Lisa Schwartz, also highlights the fact that pharmaceutical and other healthcare businesses that offer cash prizes and travel benefits to journalists are enjoying a greater market share these days.

"We believe journalists accepting these prizes are clearly creating conflicts-of-interest for themselves," the authors write.

They have even urged journalists to stop accepting sponsored awards.

The authors say that the practice of medical journalism has evolved to blur the lines between traditional news reporting and producing advertising materials that mimic reporting.

Schwartz suggests that news corporations, which depend on advertising, try to be vigilant in maintaining a separation between their editorial mission and their advertising sales.

"Journalists also need to clearly disclose when their sources have ties to industry, whether they are quoting patient groups, opinion leaders, or patients referred to them by an industry public relations office. The problem with compelling anecdotes of treatment success is that they may represent the exception, rather than a more typical experience. This can mislead audiences," says Schwartz.

The authors also write media organisations' credibility can be enhanced if journalists stop accepting funding or prizes from healthcare industries, and routinely divulge their own conflicts of interest and those of their sources.

"The news media plays a vital role. If medical journalists compromise, or appear to compromise, their independence, society loses," says Woloshin.

Source: ANI
LIN
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
January is the Thyroid Awareness Month in 2022
Menstrual Disorders
Coffee May Help You Fight Endometrial Cancer
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity 

Recommended Reading
Indian Pharma Industry
Medindia gives brief information about buy and sell details in Pharmaceutical industries in india...
Study Commissioned To Learn The Problems Faced By Pharmaceutical Companies
The Department of Scientific and Industrial Research (DSIR) in the Ministry of Science and ......
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)